Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Theratechnologies Inc. (THTX) had Revenue of $19.05M for the most recently reported fiscal quarter, ending 2025-02-28.

Quarterly Annual

Figures for fiscal quarter ending 2025-02-28

Income Statement Financials
Revenue	$19.05M
Net Income	$0.12M
Cost of Goods Sold	$3.48M
Gross Profit	$15.56M
Operating Expenses	$17.15M
Operating Income	$1.90M
Non-Operating Income/Expense	$-1.47M
Pre-Tax Income	$0.42M
Normalized Pre-Tax Income	$0.42M
Income after Taxes	$0.12M
Income from Continuous Operations	$0.12M
Consolidated Net Income/Loss	$0.12M
Normalized Income after Taxes	$0.12M
EBIT	$1.90M
EBITDA	$2.39M
Weighted-Average Shares Outstanding (Basic)	49.36M
Weighted-Average Shares Outstanding (Diluted)	50.40M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$37.82M
Property, Plant, and Equipment	$0.17M
Long-Term Assets	$18.63M
Total Assets	$56.45M
Current Liabilities	$35.15M
Long-Term Debt	$45.09M
Long-Term Liabilities	$45.77M
Total Liabilities	$80.92M
Common Equity	$-24.47M
Tangible Shareholders Equity	$-41.78M
Shareholders Equity	$-24.47M
Common Shares Outstanding	45.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-9.74M
Cash Flow from Investing Activities	$-6.90M
Cash Flow from Financial Activities	$4.67M
Beginning Cash	$15.90M
End Cash	$3.90M
Increase/Decrease in Cash	$-11.99M
Stock-Based Compensation	$0.65M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.19
Debt to Equity Ratio	-2.02
Gross Margin	81.71%
Operating Margin	9.95%
EBIT Margin	9.95%
EBITDA Margin	--
Pre-Tax Profit Margin	2.23%
Profit Margin	0.61%
Free Cash Flow	$-9.75M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.34
Inventory Turnover	0.51
Receiveable Turnover	0.85
Days Sales in Receivables	105.52
Return on Equity	-0.48%
Return on Tangible Equity	-0.28%
Return on Assets	0.21%
Return on Investments	0.57%
Book Value Per Share	$-0.53
Free Cash Flow per Share	$-0.19
Operating Cash Flow per Share	$-0.19

Data from Zacks Investment Research, Inc.